Document is current
Any future updates will be listed below
-
Authors
Liu, Li-li
Feng, Yi
Ren, Chao-yi
Liu, Yi
Zhu, Ming-hui
Hao, Guo-xiang
Gao, Tian-tian
-
Funding
Funding for this research was provided by:
2024 Tianjin Comprehensive Clinical Evaluation of Drugs Project (TZH-2024-002)
Pilot study on the standardization of comprehensive clinical evaluation of drugs (PJC202410)
2023 Tianjin Pharmacy Young and Middle-aged Research Programs (TJYX2023-03)
- License Information
-
More Information
Article History
Received: 15 April 2025
Revised: 17 September 2025
Accepted: 18 September 2025
First Online: 8 October 2025
Declarations
:
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Tianjin University Central Hospital (Protocol Code: IRB2024-074–01). Informed consent was obtained from all subjects involved in the study, and written informed consent was specifically obtained from the patients for the publication of this paper.
: Not applicable.
